Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Koch

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|September 4, 2008
Targeting the ribose and phosphate binding site of p38 mitogen-activated protein (MAP) kinase: synthesis and biological testing of 2-alkylsulfanyl-, 4(5)-aryl-, 5(4)-heteroaryl-substituted imidazolesPierre Koch, Christiane Bäuerlein, Hartmut Jank, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
1-[2-(Benzyl-amino)-4-pyrid-yl]-2-(4-fluoro-phen-yl)ethane-1,2-dioneHartmut Jahns, Pierre Koch, Dieter Schollmeyer, et al.
Acta Crystallographica. Section E, Structure Reports Online|January 5, 2011
Methyl 4-[5-(4-fluoro-phen-yl)-4-(pyridin-4-yl)-1H-imidazol-2-ylsulfan-yl]butanoatePierre Koch, Christiane Bäuerlein, Dieter Schollmeyer, et al.
Organic & Biomolecular Chemistry|September 10, 2015
An optimized and versatile synthesis to pyridinylimidazole-type p38α mitogen activated protein kinase inhibitorsAhmed El-Gokha, Stefan A Laufer, Pierre Koch
Acta Crystallographica. Section E, Structure Reports Online|May 17, 2012
4-[5-Amino-4-(4-fluoro-phen-yl)-3-(pyridin-4-yl)-1H-pyrazol-1-yl]benzo-nitrileBassam Abu Thaher, Pierre Koch, Dieter Schollmeyer, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
4-[2-(4-Fluoro-phen-yl)furan-3-yl]pyridineBassam Abu Thaher, Pierre Koch, Dieter Schollmeyer, et al.
Journal of Medicinal Chemistry|March 24, 2009
Role of the hydrogen bonding heteroatom-Lys53 interaction between the p38alpha mitogen-activated protein (MAP) kinase and pyridinyl-substituted 5-membered heterocyclic ring inhibitorsBassam Abu Thaher, Pierre Koch, Verena Schattel, et al.
ACS Pharmacology & Translational Science|March 20, 2025
Characterization of [<sup>3</sup>H]Propionylated Human Peptide YY-A New Probe for Neuropeptide Y Y<sub>2</sub> Receptor Binding StudiesFranziska Schettler, Albert O Gattor, Pierre Koch, et al.
Acta Crystallographica. Section E, Structure Reports Online|March 14, 2012
Ethyl 5-amino-3-(pyridin-4-yl)-1-(2,4,6-tri-chloro-phen-yl)-1H-pyrazole-4-carb-oxyl-ate dimethyl sulfoxide hemisolvateBassam Abu Thaher, Pierre Koch, Dieter Schollmeyer, et al.
Acta Crystallographica. Section E, Structure Reports Online|March 14, 2012
4-(4-Fluoro-phen-yl)-1-phenyl-3-(pyridin-4-yl)-1H-pyrazol-5-amineBassam Abu Thaher, Pierre Koch, Dieter Schollmeyer, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|September 4, 2008
Targeting the ribose and phosphate binding site of p38 mitogen-activated protein (MAP) kinase: synthesis and biological testing of 2-alkylsulfanyl-, 4(5)-aryl-, 5(4)-heteroaryl-substituted imidazolesPierre Koch, Christiane Bäuerlein, Hartmut Jank, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
1-[2-(Benzyl-amino)-4-pyrid-yl]-2-(4-fluoro-phen-yl)ethane-1,2-dioneHartmut Jahns, Pierre Koch, Dieter Schollmeyer, et al.
Acta Crystallographica. Section E, Structure Reports Online|January 5, 2011
Methyl 4-[5-(4-fluoro-phen-yl)-4-(pyridin-4-yl)-1H-imidazol-2-ylsulfan-yl]butanoatePierre Koch, Christiane Bäuerlein, Dieter Schollmeyer, et al.
Organic & Biomolecular Chemistry|September 10, 2015
An optimized and versatile synthesis to pyridinylimidazole-type p38α mitogen activated protein kinase inhibitorsAhmed El-Gokha, Stefan A Laufer, Pierre Koch
Acta Crystallographica. Section E, Structure Reports Online|May 17, 2012
4-[5-Amino-4-(4-fluoro-phen-yl)-3-(pyridin-4-yl)-1H-pyrazol-1-yl]benzo-nitrileBassam Abu Thaher, Pierre Koch, Dieter Schollmeyer, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
4-[2-(4-Fluoro-phen-yl)furan-3-yl]pyridineBassam Abu Thaher, Pierre Koch, Dieter Schollmeyer, et al.
Journal of Medicinal Chemistry|March 24, 2009
Role of the hydrogen bonding heteroatom-Lys53 interaction between the p38alpha mitogen-activated protein (MAP) kinase and pyridinyl-substituted 5-membered heterocyclic ring inhibitorsBassam Abu Thaher, Pierre Koch, Verena Schattel, et al.
ACS Pharmacology & Translational Science|March 20, 2025
Characterization of [<sup>3</sup>H]Propionylated Human Peptide YY-A New Probe for Neuropeptide Y Y<sub>2</sub> Receptor Binding StudiesFranziska Schettler, Albert O Gattor, Pierre Koch, et al.
Acta Crystallographica. Section E, Structure Reports Online|March 14, 2012
Ethyl 5-amino-3-(pyridin-4-yl)-1-(2,4,6-tri-chloro-phen-yl)-1H-pyrazole-4-carb-oxyl-ate dimethyl sulfoxide hemisolvateBassam Abu Thaher, Pierre Koch, Dieter Schollmeyer, et al.
Acta Crystallographica. Section E, Structure Reports Online|March 14, 2012
4-(4-Fluoro-phen-yl)-1-phenyl-3-(pyridin-4-yl)-1H-pyrazol-5-amineBassam Abu Thaher, Pierre Koch, Dieter Schollmeyer, et al.
Pageof 8